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Abstract
Background: 5-Hydroxymethylcytosine (5hmC) was recently found to be abundantly present in certain cell types,
including embryonic stem cells. There is growing evidence that TET proteins, which convert 5-methylcytosine
(5mC) to 5hmC, play important biological roles. To further understand the function of 5hmC, an analysis of the
genome-wide localization of this mark is required.
Results: Here, we have generated a genome-wide map of 5hmC in human embryonic stem cells by hmeDIP-seq,
in which hydroxymethyl-DNA immunoprecipitation is followed by massively parallel sequencing. We found that
5hmC is enriched in enhancers as well as in gene bodies, suggesting a potential role for 5hmC in gene regulation.
Consistent with localization of 5hmC at enhancers, 5hmC was significantly enriched in histone modifications
associated with enhancers, such as H3K4me1 and H3K27ac. 5hmC was also enriched in other protein-DNA
interaction sites, such as OCT4 and NANOG binding sites. Furthermore, we found that 5hmC regions tend to have
an excess of G over C on one strand of DNA.
Conclusions: Our findings suggest that 5hmC may be targeted to certain genomic regions based both on gene
expression and sequence composition.
Background
Cytosine DNA methylation (5-methylcytosine (5mC)) is
an epigenetic mark that is widespread in both animals
and plants, and appears to play important roles in various
biological processes, such as gene silencing and imprint-
ing. Recently, studies have shown that embryonic stem
cells (ESCs) and Purkinje neurons contain high levels of
5-hydroxymethylcytosine (5hmC) [1,2]. Human TET1, a
2-oxoglutarate- and Fe(II)-dependent enzyme, has been
shown to catalyze the conversion of 5mC to 5hmC both
in vitro and in vivo [1]. Subsequently, all mouse Tet pro-
teins, Tet1, Tet2 and Tet3, were shown to be able to con-
v e r t5 m Ct o5 h m C[ 3 ] .D i s r u p t i o ni nh u m a nT E T 1a n d
TET2 is associated with diseases such as MLL-associated
leukemia [4] and myeloproliferative disorders [5]. Studies
have suggested that 5hmC inhibits the methyl-CpG-bind-
ing protein MeCP2 from binding DNA [6]. In addition to
the exclusion of methyl-CpG-binding proteins, 5hmC
may recruit unknown 5hmC binding protein(s). More-
over, because the DNA methyltransferase DNMT1 binds
poorly to 5hmC [1,7], it is possible that 5hmC plays a
role in excluding DNMT1 from methylating cytosines
and thus may promote DNA demethylation. Importantly,
5hmC diminishes as embryonic stem cells (ESCs) differ-
entiate, suggesting that 5hmC may play specific roles in
ESCs. Indeed, mouse Tet1 has been shown to be required
for ESC maintenance [3]. The function of 5hmC in mam-
mals remains poorly understood. To further understand
the role of 5hmC, it is necessary to understand where
5hmC localizes in the genome. Very recently, a genome-
wide map of 5hmC was reported in mouse cerebellum
[8]. 5hmC was chemically tagged and affinity enriched,
and the purified DNA was sequenced. The authors found
that 5hmC is enriched over genes and is positively corre-
lated with expression levels [8].
Recently, commercial antibodies specific to 5hmC
have become available. While these antibodies specifi-
cally recognize 5hmC, it is important to note that they
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any medium, provided the original work is properly cited.tend to prefer densely 5-hydroxymethylated sites to sin-
gle 5hmC sites (Figure S1 in Additional file 1). Here we
generated genome-wide maps of 5hmC in human ESCs
(hESCs) by performing hydroxymethyl-DNA immuno-
precipitation followed by massively parallel sequencing
with an Illumina Genome Analyzer (hmeDIP-seq). As
did Song et al. [8], we found that a large fraction of
5hmC peaks were enriched over genes. However, we
also found that 5hmC is enriched over predicted hESC
enhancers, further suggesting a potential role of 5hmC
in gene regulation. Moreover, we observed enrichment
of 5hmC peaks with transcription binding sites such as
those of pluripotency factors OCT4 and NANOG. In
addition, we found that 5hmC regions correspond to
genomic regions that are GC-skewed.
Results and discussion
5hmC is enriched over genic regions
To generate genome-wide maps of 5hmC, we performed
two hmeDIP-seq experiments using two different
commercial antibodies (Active Motif and Diagenode).
HmeDIP-seq experiments generated 10 to 30 million
reads that uniquely mapped to the human genome
(Figure 1a). We defined regions for both maps by using
both input DNA and ‘no antibody’ sequencing reads as
background controls (see Materials and methods). We
selected 15,324 regions that were called significant in
both hmeDIP-seq experiments. The average length of
the defined regions was 1.5 kb, and consistent with pre-
vious findings with chemically labeling methods [8], sex
chromosomes were depleted in 5hmC regions (Figure
S2a-c in Additional file 1).
The chromosomal distribution of 5hmC regions sug-
gested that 5hmC is within gene-rich chromosomal
domains (Figure 1b). Indeed, 46.2% of defined 5hmC
regions overlapped with RefSeq annotated genes, sug-
gesting a potential role of 5hmC in gene regulation.
Plotting 5hmC peaks over RefSeq genes, we found that
5hmC tends to localize to transcribed regions (bodies)
of genes in addition to immediate upstream regions
(Figure S3a in Additional file 1). The distribution of
expression levels of genes with 5hmC peaks was similar
to levels of all genes, suggesting that 5hmC may not lin-
early correlate with expression levels (Figure S3b in
Additional file 1). Plotting the distribution of 5hmC
peaks over RefSeq genes with different expression levels,
we observed that 5hmC is enriched near the transcrip-
tion start sites of lowly expressed genes, whereas 5hmC
is depleted at transcription start sites of highly expressed
genes (Figure 1c). This is in contrast to data reported by
Song et al. [8] that suggested that 5hmC levels positively
correlate with expression in mouse cerebellum, suggest-
ing possible differences in the role of 5hmC in different
tissues.
5hmC is enriched over enhancers
Because a large proportion of 5hmC peaks did not fall into
genic regions, we examined whether 5hmC co-localized
with predicted enhancers in hESCs [9]. Indeed, we found
that 5hmC peaks were highly enriched over enhancers
(Figure 2a), and the magnitude of enrichment was greater
than that observed over genes. We found that 3,028 enhan-
cers overlapped with 5hmC peaks. 5hmC enrichment at
enhancers was verified using a method that can measure
5hmC levels at CCGG sites by glucosylating 5hmC and
digesting with the MspI restriction enzyme (MspI can
digest 5hmC, but not glucosylated 5hmC) [10] (Figure 2b).
Quantitative PCR assays across selected CCGG sites sug-
gested that 5hmC levels at tested 5hmC peaks ranged from
9.6% to 36.4%, whereas at control regions the levels ranged
from 0.5% to 2.7%. Enhancers are marked by chromatin
signatures such as histone H3 lysine 4 monomethylation
(H3K4me1) and histone H3 lysine 27 acetylation
(H3K27ac) [11]. We confirmed that 5hmC peaks signifi-
cantly overlapped with defined H3K4me1 and H3K27ac
regions from a separate study [12] (Figure 2c), and 5hmC-
marked enhancers overlapped with both of these marks to
a greater extent compared to all predicted enhancers (Fig-
ure 2d). Remarkably, we observed positive correlations
between 5hmC and H3K4me1 and H3K27ac despite com-
paring data from different cell lines. We next tested
whether 5hmC marks active or poised enhancers [12], and
found that 5hmC is more likely associated with active
enhancers (Figure S4a, b in Additional file 1). Because
enhancers regulate gene expression in a cell-type-specific
manner [11], we sought to test whether genes specifically
expressed in hESCs are associated with 5hmC. We defined
the genes closest to each given 5hmC peak (measured
from transcription start sites; maximum distance allowed =
100 kb) as 5hmC-regulated genes. We next defined hESC-
specific expressed genes by using a published RNA-seq
data set (H1 hESCs versus IMR-90 fibroblast cells) [9] and
only selecting genes that were expressed in hESCs (reads
per kilobase of exon model per million mapped reads
(RPKM) ≥ 0.5) and silent in IMR-90 cells (RPKM = 0).
Interestingly, we found that 42.5% of hESC-specific
expressed genes overlapped with 5hmC peaks, whereas
27.5% of all genes overlapped with 5hmC peaks (P <
0.0001; Figure 2e). Hence, in hESCs, 5hmC shows some
preference for genes specifically expressed in hESCs. This
is consistent with results from previous studies suggesting
that predicted enhancers from a particular cell-type mark
cell-specific expressed genes [11].
To examine whether 5hmC peaks are associated with
genes with specific functions, we performed gene ontol-
ogy analyses using GREAT [13], which enables func-
tional analysis of cis-regulatory regions such as
enhancers. Interestingly, 5hmC-associated genes tended
to function in processes such as embryonic pattern
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Figure 1 High resolution map of hydroxymethylcytosine in human embryonic stem cells. (a) Genome-browser view of hmeDIP-seq data.
Two hmeDIP-seq datasets along with input DNA and ‘no antibody’ controls are shown. Each track is represented as normalized density of reads
(reads/bp/million uniquely mapping reads). (b) Gene density (genes/bp) and 5hmC peak density (peaks/bp) in chromosome 3. (c) 5hmC over
genes with different expression levels. 5hmC peak density was plotted over RefSeq genes in 300-bp bins. Plots were smoothed by taking the
moving average over ± 2 bins. Published RNA sequencing data [9] were used to rank the genes. TSS, transcription start site; TTS, transcription
termination site.
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Figure 2 Co-localization of 5hmC with enhancers. (a) 5hmC over enhancers in hESCs. 5hmC peak density was plotted over predicted hESC
enhancers [9,21] in 100-bp windows. (b) Verfication of 5hmC at enhancers by measuring 5hmC levels at CCGG sites. Four 5hmC peaks at
enhancers and two control regions were tested. MspI cannot cut glucosylated-5hmC but is able to cut 5hmC; therefore, copy numbers of MspI
+ beta-glucosyltransferase (BGT) represent 5hmC levels. On the other hand, HpaII can only cut unmodified DNA; therefore, copy numbers
represent 5hmC + 5mC levels. Background signal was subtracted from the copy number of each sample and then normalized to the undigested
glucosylated sample. Genomic locations of tested cytosines are indicated. Error bars represent the standard deviation. (c) Histone modifications
over 5hmC peaks. The overlap of 5hmC peaks with previously defined H3K4me1- and H3K27ac-enriched regions [12] was calculated. Random
regions with the same number and size distribution as 5hmC peaks were generated and overlap with histone modifications was calculated 100
times. Error bars represent standard deviation. (d) Histone modifications over 5hmC-marked enhancers. Predicted enhancers that overlapped
with 5hmC peaks were selected. The overlap of these 5hmC-marked enhancers, as well as all predicted enhancers, with previously defined
H3K4me1 and H3K27ac enriched regions [12] was calculated. Random regions with the same number and size distribution as the enhancers
were generated and overlap with histone modifications was calculated 100 times. Error bars represent standard deviation. (e) hESC-specific
expressed genes significantly overlap with 5hmC peaks. hESC-specific genes were defined as genes that were expressed in hESCs (reads
per kilobase of exon model per million mapped reads (RPKM) ≥ 0.5) and silent in IMR90 cells (RPKM = 0) using published RNA-seq data [9].
*P < 0.0001.
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Page 4 of 8specification, cerebellum morphogenesis, and other
developmental processes (Figure S5 in Additional file 1).
5hmC is enriched over transcription factor binding sites
Because predicted enhancers of ESCs are enriched in
some known ESC-specific transcription factors [11], we
next examined the overlap of 5hmC with previously iden-
tified transcription factor binding sites (TFBSs) in hESCs
[14]. Interestingly, we found that 5hmC regions were
enriched over pluripotency factors NANOG and OCT4
binding sites, as well as the sites of insulator binding pro-
tein CTCF (Figure 3a-c). This result, along with the fact
that 5hmC is enriched over enhancers, suggests that
5hmC may mark protein-DNA interaction sites. Visual
inspection of certain hESC-specific genes [15] further
confirmed overlaps between 5hmC and loci such as
enhancers and TFBSs (Figure S6a,b in Additional file 1).
Bisulfite sequencing and methylation-sensitive restriction
digestion methods, both techniques that cannot distin-
guish 5mC and 5hmC, have suggested that DNA methy-
lation levels are reduced at TFBSs and enhancers [9,12].
Because we observed enrichment of 5hmC at these sites,
it is likely that the low levels of DNA methylation
observed by the previous studies are at least in part
5hmC. This suggests that 5mC levels may be even lower
than previously measured by bisulfite sequencing and
methylation-sensitive restriction digestion methods. It is
plausible to hypothesize that 5mC blocks enhancer pro-
teins and transcription factors from binding DNA. On
the contrary, 5hmC inhibits both the DNA methyltrans-
ferase DNMT1 and the methyl-CpG-binding protein
MeCP2 from binding [1,6,7]. Hence, 5hmC may function
in negatively regulating 5mC levels at certain protein-
DNA interaction sites in order to allow protein-DNA
binding of enhancer proteins and transcription factors.
5hmC regions are GC-skewed
We next examined the sequence contexts associated with
5hmC. By plotting the frequencies of nucleotides, we
observed that 5hmC regions are enriched in GC content
(Figure 4a, b). Furthermore, curiously, we found that
5hmC regions are GC-skewed, where Gs are enriched over
Cs in the 5’ ends of the regions, whereas the 3’ ends of the
regions had the opposite skew, where Cs are enriched over
Gs (Figure 4a, b). The GC-skew was observed in 5hmC
regions overlapping with genes and enhancers as well as
5hmC regions not overlapping with these elements, sug-
gesting that this sequence composition is a common fea-
ture of all 5hmC regions (Figure S7a-c in Additional file 1).
Hence, 5hmC may be targeted to GC skew regions.
Because changes in the sign of GC-skew (from G rich to C
rich) is thought to occur at sites of replication termination
[16-18] as well as recombination hotspots [19], a specula-
tion is that 5hmC may also mark termination sites of DNA
replication or sites of recombination. With the same rea-
soning that 5hmC may mark sites of protein-DNA binding,
such as enhancers and transcription factors, an attractive
hypothesis is that 5hmC may allow binding of factors of
replication or recombination.
Conclusions
We have generated the first genome-wide map of 5hmC in
hESCs, and have found that 5hmC localizes to enhancers
and gene bodies. 5hmC also tended to localize to other
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Figure 3 Co-localization of 5hmC with transcription factor
binding sites. (a) 5hmC regions over CTCF binding sites in hESCs.
5hmC peak density was plotted over the ± 2 kb relative to the center
of defined binding sites in 100-bp windows. (b) Over NANOG
binding sites in hESCs. (c) Over OCT4 binding sites in hESCs.
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Page 5 of 8protein-DNA interaction sites such as TFBSs, suggesting a
role of 5hmC in gene regulation. Finally, we found a novel
characteristic of the DNA sequences associated with
5hmC peaks, GC-skew, which suggests the possibility that
sequence composition may be a signal for the deposition
of this epigenetic mark.
Materials and methods
Hydroxymethyl-DNA immunoprecipitation and Illumina
library generation/sequencing
hmeDIP experiments were performed on HSF1 hESCs
as previously described [20] using commercial antibodies
specific to 5hmC, except that Illumina adapter ligated
DNA fragments were used as the input for the immuno-
precipitation. Two experiments, one using rabbit poly-
clonal antibody (Active Motif, Carlsbad, CA, USA) and
the other using mouse monoclonal antibody (Diagenode,
Sparta, NJ, USA), were performed using 5 μg per immu-
noprecipitation. Input genomic DNA and no antibody
controls were also kept for sequencing. Illumina libraries
were generated and sequenced on an Illumina Genome
Analyzer per the manufacturer’s instructions.
Data processing and analysis
Sequenced reads were base-called using the standard Illu-
mina software. Reads were trimmed down to 50 bases
d u et ol o wq u a l i t yb a s ec a l l si nt h e3 ’ end of reads, and
aligned to hg18 with Bowtie (v.0.12.4) allowing up to
three mismatches. Only uniquely mapping reads were
kept, and identical reads were collapsed to one read.
Because the reads represent the ends of DNA libraries,
for the downstream analyses, the reads were extended to
represent the average fragment size of the libraries. All
sequencing data have been deposited in Gene Expression
Omnibus [GEO:GSE27627]. Regions were defined by
using SICER (v.1.03). Only regions that were called by
using both input and ‘no antibody’ as a background con-
trol with Benjamini corrected false discovery rate < 0.05
were kept. Finally, only regions called in both antibody
hmeDIP-seq experiments were kept and analyzed. Gene
ontology analysis was performed using the Genomic
Regions Enrichment of Annotations Tool (GREAT) [13].
Published hESC RNA-seq data [9] were used for expres-
sion analyses.
Dot blots
Fully hydroxymethylated DNA was produced by end-
point PCR using Phusion polymerase (NEB, Ipswich,
MA, USA) and hm-dCTP (Bioline, Tauton, MA, USA)
followed by PCR purification (Qiagen, Valencia, CA,
USA). Unmethylated and fully methylated control DNAs
were produced in the same manner with dCTP and
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Page 6 of 8m-dCTP (NEB, Ipswich, MA, USA), respectively. Var-
ious amounts of DNA were denatured, snap cooled and
dotted onto positively charged nylon membranes
(Roche, Indianapolis, IN, USA). Membranes were cross-
linked, blocked with 5% milk, and incubated with Active
Motif (1:10,000) 5-hmC antibody for 1 hour. Mem-
branes were washed and then incubated with anti-rabbit
secondary horseradish peroxidase-linked antibody (CST,
Danvers, MA, USA) for 1 hour, washed, and developed
with ECL reagent (CST) and Biomax MS film (Kodak).
DNA sequences were (primer sequences in bold):
12 CG-TACTCTATACTCTACTCATCATTACAC
GCGCGATATCGTTAACGATAATTCGCGCGATTAC-
GATCGATAACGCGTTAATATGAGATATGAGAT
GTGTATG; 6 CG-TACTCTATACTCTACTCATCAT-
TACAATATATATATCGTTAACGATAATTCGCGCG
ATTACGATTTATAATTAATTAATATGAGATAT-
GAG ATGTGTATG; 3 CG-TACTCTATACTCTACTC
ATCATTACAATATATATATAATTAATTATAATTC
GCGAAATTACGATTTATAATTAATTAATATGAGA-
TATGAGATGTGTATG;1C G - TACTCTATACTC-
TACTCATCATTACAATAT ATATATAATTAATTA
TAATTAACGAAATTATAATTTATAATTAATTAA
TATGAGATATGAGATGTGTATG.
Validation of hydroxymethylated loci using MspI
restriction enzyme and beta-glucosyltransferase
Human stem cell genomic DNA (5 to 10 μg) was trea-
ted with the EpiMark 5-hmC and 5-mC Analysis Kit as
per the included protocol (NEB). Briefly, DNA was
either glucosylated with beta-glucosyltransferase and
UDP-Glc or mock treated with beta-glucosyltransferase
and no UDP-Glc for 12 to 18 hours. These reactions
were then split into three and mock digested, digested
with MspI, or with HpaII for at least 4 hours. Samples
were treated with proteinase K that was then heat
inactivated. All DNA were diluted to a final concentra-
tion of 16 ng/μl to be used for PCR analysis. Quantita-
tive PCR was completed with iQ SYBR Green
Supermix (Biorad, Hercules, CA, USA) using a
CFX384 Real-Time PCR Detection System (Biorad).
Primers used for quantitative PCR are listed in Table
S1 in Additional file 1.
Additional material
Additional file 1: Supplementary figures and table. Figure S1: 5hmC
dot blots on oligos with varying amounts of 5hmC. Figure S2:
characterization of defined 5hmC peaks. Figure S3: correlation of 5hmC
and gene expression. Figure S4: 5hmC and different classes of putative
enhancers [12]. Figure S5: gene ontology analysis of genes that overlap
with 5hmC peaks [13]. Figure S6: genome-browser views of 5hmC,
enhancers and TFBSs [9,14,15]. Figure S7: sequence composition over
5hmC regions in different genomic locations. Table S1: primers used for
quantitative PCR.
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5hmC: 5-hydroxymethylcytosine; 5mC: 5-methylcytosine; bp: base pair; ESC:
embryonic stem cell; H3K4me1: histone H3 mono-methylated at lysine 4;
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